382 related articles for article (PubMed ID: 21178018)
21. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.
de Antonio M; Lupon J; Galan A; Vila J; Urrutia A; Bayes-Genis A
Am Heart J; 2012 May; 163(5):821-8. PubMed ID: 22607860
[TBL] [Abstract][Full Text] [Related]
22. Soluble ST2 in ambulatory patients with heart failure: Association with functional capacity and long-term outcomes.
Felker GM; Fiuzat M; Thompson V; Shaw LK; Neely ML; Adams KF; Whellan DJ; Donahue MP; Ahmad T; Kitzman DW; Piña IL; Zannad F; Kraus WE; O'Connor CM
Circ Heart Fail; 2013 Nov; 6(6):1172-9. PubMed ID: 24103327
[TBL] [Abstract][Full Text] [Related]
23. Noninvasive Prognostic Biomarkers for Left-Sided Heart Failure as Predictors of Survival in Pulmonary Arterial Hypertension.
Simpson CE; Damico RL; Hassoun PM; Martin LJ; Yang J; Nies MK; Vaidya RD; Brandal S; Pauciulo MW; Austin ED; Ivy DD; Nichols WC; Everett AD
Chest; 2020 Jun; 157(6):1606-1616. PubMed ID: 31987881
[TBL] [Abstract][Full Text] [Related]
24. N-terminal fraction of pro-B-type natriuretic peptide versus clinical risk scores for prognostic stratification in chronic systolic heart failure.
Arzilli C; Aimo A; Vergaro G; Ripoli A; Senni M; Emdin M; Passino C
Eur J Prev Cardiol; 2018 May; 25(8):889-895. PubMed ID: 29569494
[TBL] [Abstract][Full Text] [Related]
25. N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease.
Bibbins-Domingo K; Gupta R; Na B; Wu AH; Schiller NB; Whooley MA
JAMA; 2007 Jan; 297(2):169-76. PubMed ID: 17213400
[TBL] [Abstract][Full Text] [Related]
26. Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure.
Rehman SU; Mueller T; Januzzi JL
J Am Coll Cardiol; 2008 Oct; 52(18):1458-65. PubMed ID: 19017513
[TBL] [Abstract][Full Text] [Related]
27. Heart failure mortality according to acute variations in N-terminal pro B-type natriuretic peptide and cystatin C levels.
Carrasco-Sánchez FJ; Pérez-Calvo JI; Morales-Rull JL; Galisteo-Almeda L; Páez-Rubio I; Barón-Franco B; Aguayo-Canela M; Pujol-De la llave E
J Cardiovasc Med (Hagerstown); 2014 Feb; 15(2):115-21. PubMed ID: 24522084
[TBL] [Abstract][Full Text] [Related]
28. Soluble ST2 is a marker for acute cardiac allograft rejection.
Pascual-Figal DA; Garrido IP; Blanco R; Minguela A; Lax A; Ordoñez-Llanos J; Bayes-Genis A; Valdés M; Moore SA; Januzzi JL
Ann Thorac Surg; 2011 Dec; 92(6):2118-24. PubMed ID: 22035779
[TBL] [Abstract][Full Text] [Related]
29. Combined use of high-sensitivity ST2 and NTproBNP to improve the prediction of death in heart failure.
Bayes-Genis A; de Antonio M; Galán A; Sanz H; Urrutia A; Cabanes R; Cano L; González B; Díez C; Pascual T; Elosúa R; Lupón J
Eur J Heart Fail; 2012 Jan; 14(1):32-8. PubMed ID: 22179033
[TBL] [Abstract][Full Text] [Related]
30. Predictive Ability of Novel Cardiac Biomarkers ST2, Galectin-3, and NT-ProBNP Before Cardiac Surgery.
Polineni S; Parker DM; Alam SS; Thiessen-Philbrook H; McArthur E; DiScipio AW; Malenka DJ; Parikh CR; Garg AX; Brown JR
J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 29982227
[TBL] [Abstract][Full Text] [Related]
31. Soluble ST2 and N-terminal pro-brain natriuretic peptide combination. Useful biomarker for predicting outcome of childhoodpulmonary arterial hypertension.
Chida A; Sato H; Shintani M; Nakayama T; Kawamura Y; Furutani Y; Inai K; Saji T; Matsuoka R; Nonoyama S; Nakanishi T
Circ J; 2014; 78(2):436-42. PubMed ID: 24304538
[TBL] [Abstract][Full Text] [Related]
32. Usefulness of soluble concentrations of interleukin family member ST2 as predictor of mortality in patients with acutely decompensated heart failure relative to left ventricular ejection fraction.
Manzano-Fernández S; Mueller T; Pascual-Figal D; Truong QA; Januzzi JL
Am J Cardiol; 2011 Jan; 107(2):259-67. PubMed ID: 21211603
[TBL] [Abstract][Full Text] [Related]
33. Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study.
Januzzi JL; Peacock WF; Maisel AS; Chae CU; Jesse RL; Baggish AL; O'Donoghue M; Sakhuja R; Chen AA; van Kimmenade RR; Lewandrowski KB; Lloyd-Jones DM; Wu AH
J Am Coll Cardiol; 2007 Aug; 50(7):607-13. PubMed ID: 17692745
[TBL] [Abstract][Full Text] [Related]
34. Increased soluble ST2 predicts long-term mortality in patients with stable coronary artery disease: results from the Ludwigshafen risk and cardiovascular health study.
Dieplinger B; Egger M; Haltmayer M; Kleber ME; Scharnagl H; Silbernagel G; de Boer RA; Maerz W; Mueller T
Clin Chem; 2014 Mar; 60(3):530-40. PubMed ID: 24401186
[TBL] [Abstract][Full Text] [Related]
35. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
[TBL] [Abstract][Full Text] [Related]
36. Independent and additive prognostic ability of serum carboxy-terminal telopeptide of collagen type-I in heart failure patients: a multi-marker approach with high-negative predictive value to rule out long-term adverse events.
Tziakas DN; Chalikias GK; Stakos D; Chatzikyriakou SV; Papazoglou D; Mitrousi K; Lantzouraki A; Thomaidi A; Boudoulas H; Konstantinides S
Eur J Prev Cardiol; 2012 Feb; 19(1):62-71. PubMed ID: 20479644
[TBL] [Abstract][Full Text] [Related]
37. The Prognostic Value of Serum Levels of Heart-Type Fatty Acid Binding Protein and High Sensitivity C-Reactive Protein in Patients With Increased Levels of Amino-Terminal Pro-B Type Natriuretic Peptide.
Jeong JH; Seo YH; Ahn JY; Kim KH; Seo JY; Kim MJ; Lee HT; Park PW
Ann Lab Med; 2016 Sep; 36(5):420-6. PubMed ID: 27374706
[TBL] [Abstract][Full Text] [Related]
38. Assessment of a multi-marker risk score for predicting cause-specific mortality at three years in older patients with heart failure and reduced ejection fraction.
Bjurman C; Holmström A; Petzold M; Hammarsten O; Fu ML
Cardiol J; 2015; 22(1):31-6. PubMed ID: 24526512
[TBL] [Abstract][Full Text] [Related]
39. Risk stratification with the use of serial N-terminal pro-B-type natriuretic peptide measurements during admission and early after discharge in heart failure patients: post hoc analysis of the PRIMA study.
Eurlings LW; Sanders-van Wijk S; van Kraaij DJ; van Kimmenade R; Meeder JG; Kamp O; van Dieijen-Visser MP; Tijssen JG; Brunner-La Rocca HP; Pinto YM
J Card Fail; 2014 Dec; 20(12):881-90. PubMed ID: 25175696
[TBL] [Abstract][Full Text] [Related]
40. Biomarker-assist score for reverse remodeling prediction in heart failure: The ST2-R2 score.
Lupón J; Gaggin HK; de Antonio M; Domingo M; Galán A; Zamora E; Vila J; Peñafiel J; Urrutia A; Ferrer E; Vallejo N; Januzzi JL; Bayes-Genis A
Int J Cardiol; 2015 Apr; 184():337-343. PubMed ID: 25734941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
